Librede Inc. Receives Patent for Tetrahydrocannabinolic acid (THCA) Production in Yeast

Editorial & Advertiser Disclosure Global Banking And Finance Review is an independent publisher which offers News, information, Analysis, Opinion, Press Releases, Reviews, Research reports covering various economies, industries, products, services and companies. The content available on is sourced by a mixture of different methods which is not limited to content produced and supplied by various staff writers, journalists, freelancers, individuals, organizations, companies, PR agencies Sponsored Posts etc. The information available on this website is purely for educational and informational purposes only. We cannot guarantee the accuracy or applicability of any of the information provided at with respect to your individual or personal circumstances. Please seek professional advice from a qualified professional before making any financial decisions. also links to various third party websites and we cannot guarantee the accuracy or applicability of the information provided by third party websites. Links from various articles on our site to third party websites are a mixture of non-sponsored links and sponsored links. Only a very small fraction of the links which point to external websites are affiliate links. Some of the links which you may click on our website may link to various products and services from our partners who may compensate us if you buy a service or product or fill a form or install an app. This will not incur additional cost to you. A very few articles on our website are sponsored posts or paid advertorials. These are marked as sponsored posts at the bottom of each post. For avoidance of any doubts and to make it easier for you to differentiate sponsored or non-sponsored articles or links, you may consider all articles on our site or all links to external websites as sponsored . Please note that some of the services or products which we talk about carry a high level of risk and may not be suitable for everyone. These may be complex services or products and we request the readers to consider this purely from an educational standpoint. The information provided on this website is general in nature. Global Banking & Finance Review expressly disclaims any liability without any limitation which may arise directly or indirectly from the use of such information.

Librede, a synthetic biology company based in Southern California, has been granted a new patent to produce tetrahydrocannabinolic acid (THCA) in yeast. THCA is the precursor to tetrahydrocannabinol (THC), which is the most well-known cannabinoid; THC has been an FDA approved pharmaceutical compound for decades (a.k.a. dronabinol). The cannabis plant does not produce THC; instead it produces THCA, which is converted to THC by various methods such as heating. The patent issued to Librede shows a process for producing THCA via fermentation using bakers yeast and low-cost feedstocks. This patent is one of many that Librede has been awarded surrounding the full biosynthesis of cannabinoids, such as cannabidiol (CBD), cannabigerol (CBG), and now THC. Librede plans to continue to expand on its IP portfolio and increase production.

Dr. Anthony Farina, Libredes Chief Scientific Officer, states: We have been working on laying the foundation for a new chemical platform that will gain access to high value natural products. This new patent, which adds to our portfolio, demonstrates that THCA can be made using yeast, allowing for highly pure and consistent therapeutics to be produced at lower costs. We are working hard to improve the efficiency of our system to streamline the production of these compounds.

Biosynthesis of high value complex natural products offers several advantages over agricultural production such as: consistency, supply chain stability, large reductions in costs, and reduced carbon footprint (less land, water, energy, no fertilizers, and no pesticides). The ability to obtain highly pure compounds in an environmentally and economically sustainable fashion is at the core of Libredes mission.

Dr. Jason Poulos, CEO of Librede, explains: Natural products have been and will continue to be a source of valuable therapeutics. Nature is the source, but it is not a sustainable factory. Large scale agricultural production of low abundant chemicals can have negative effects on the environment. Instead of using natural resources to grow massive fields of cannabis to make cannabinoids, fermentation offers us a sustainable solution. The future of cannabinoid production is coming into focus, and its looking more and more like a brewery.

About Librede:

Librede is a synthetic biology company that uses biologically-based approaches to produce natural products with a focus on cannabinoids.

Dr. Jason Poulos, Ph.D.
Chief Executive Officer
[email protected]